"World's First Pancreatic Cancer Imaging Agent Test Conducted in W. MI"
Originally Published 1 year ago — by WOODTV.com
A West Michigan man with pancreatic cancer became the first person in the world to test a new imaging agent as part of a clinical trial conducted by BAMF Health, which aims to improve the detection of the disease. The imaging agent, labeled with a radioactive isotope, was used in conjunction with a total-body PET/CT scanner to localize the presence of the disease in the patient. The trial's results could potentially lead to the development of targeted treatments for pancreatic cancer, which currently do not exist.